Home›Stock Screener›Gujarat Inject

Gujarat Inject Share Price Today | Stock Price & Gujarat Inject Share Screener

GUJINJEC Pharmaceuticals
Live Share Price BSE
₹9.09
▼ -0.09 (-0.98%)
2026-10-05 00:00:00

As of October 5, 2026, the live Gujarat Inject share price (BSE: GUJINJEC) is ₹9.09, down 0.98% from the previous close, with shares trading between ₹8.77 and ₹9.18 in today's trading session, and a 52-week range of ₹9.08–₹130.90. Check Gujarat Inject yearly highs lows for the annual price range and momentum. Use the Gujarat Inject stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gujarat Inject opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹12 and net income of ₹1, with EBITDA of ₹1, an operating margin of 4.0% and a profit margin of 8.3%.

Gujarat Inject Market Cap ₹48.99 Cr.
GUJINJEC P/E Ratio (TTM) 15.00
Gujarat Inject P/B Ratio 4.75
EPS (TTM) ₹0.70
Dividend Yield -
Debt to Equity 0.08
GUJINJEC 52 Week High ₹130.90
Gujarat Inject 52 Week Low ₹9.08
Operating Margin 4.00%
Profit Margin 8.33%
GUJINJEC Revenue (TTM) ₹12.00
EBITDA ₹1.00
Net Income ₹1.00
Total Assets ₹12.00
Total Equity ₹10.00

Gujarat Inject Share Price Chart

Track the current stock price of Gujarat Inject with an interactive chart. Analyse GUJINJEC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gujarat Inject stock quote in one place.

The quote of ₹9.09 sits between the 52-week low of ₹9.08 and the 52-week high of ₹130.90, and the latest session moved -0.98% from the previous close.

Gujarat Inject Company Profile - Fundamental Screener

Screen Gujarat Inject company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GUJINJEC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE659F01014.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE659F01014

Gujarat Inject Balance Sheet Screener

Screen GUJINJEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹12 against total liabilities of ₹12, up from ₹9 in 2024.

Latest statistics put total assets at ₹12 and shareholder funds at ₹10, with a leverage ratio of 0.08.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 12 9 0 0 0 0 0 0 0 0
Current Assets 9 6 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 12 9 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 10 9 -1 -1 -1 -1 -1 -1 -1 -1
Share Capital 15 11 5 5 5 5 5 5 5 5
Reserves & Surplus -5 -6 -6 -6 -6 -6 -6 -6 -6 -6

Gujarat Inject Income Statement Screener - Profit & Revenue Analysis

Screen Gujarat Inject income statement and profit fundamentals. Analyze GUJINJEC quarterly results. Gujarat Inject reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹12 and net profit was ₹1, equal to earnings per unit of ₹0.30, at an operating margin of 4%.

In that period expenses were ₹11, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹19 and net profit of ₹1.

Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 12 19 6 1 0 0 0 0 0 2 0 0
Expenses 11 18 6 1 0 0 0 0 0 2 0 0

Operating Costs and Margins

EBITDA 1 1 0 0 0 0 0 0 0 0 0 0
Operating Profit % 4.00% 6.00% 1.00% -217.00% -200.00% -982.00% 0.00% 0.00% 0.00% 1.00% 4.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 1 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 0 0 0 0 0 0 0 0 0 0
EPS 0.30 0.70 0.09 0.05 0.00 -0.12 0.00 -0.01 -0.03 0.02 4.70 -0.01

Gujarat Inject Cash Flow Screener - Liquidity Fundamentals

Screen GUJINJEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities used ₹6, and net cash flow was an inflow of ₹3.

Over the same period, investing activities provided ₹0 and financing activities provided ₹9.

Item 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Cash from Operations and Investing

Operating Activities -6 0 0 0 0 0 0 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0

Financing and Net Cash

Financing Activities 9 0 0 0 0 0 0 0 0 0
Net Cash Flow 3 0 0 0 0 0 0 0 0 0

Gujarat Inject Shareholding Pattern Screener

See Gujarat Inject shareholding pattern with promoter, FII, and DII holdings. Check Gujarat Inject promoter holding and ownership changes for GUJINJEC on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 0.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 83.95%, spread across 7,303 shareholders.

The shareholder count was 7,303 in 2025-Mar, compared with 7,303 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Apr 2024-Jun 2024-Sept 2024-Dec

Promoter Holding

Promoter Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 83.95% 83.95% 92.83% 88.24% 86.82% 86.79% 86.80% 85.91%
Other Holding 16.05% 16.05% 7.17% 11.75% 13.18% 13.21% 13.20% 14.08%
Shareholder Count 7,303 7,303 8,151 6,721 6,706 6,698 6,627 6,773

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gujarat Inject. Gujarat Inject dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Gujarat Inject.

Gujarat Inject Stock Index Membership - Nifty & Sensex

See which indices include Gujarat Inject stock. Check GUJINJEC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Gujarat Inject is not part of any tracked indices.
Only major market indices are tracked in our system.

Gujarat Inject Market Events Screener - Corporate Actions

Get Gujarat Inject corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gujarat Inject stock events that may affect GUJINJEC share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2025, with a record date of November 13, 2025.

It is followed by Annual General Meeting dated September 30, 2025 and Quarterly Result Announcement dated August 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2025-11-13 2025-11-13 Quarterly Result Announcement NA 2.08%
2025-09-30 2025-09-30 Annual General Meeting NA -0.40%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 1.33%
2025-05-20 2025-05-20 Quarterly Result Announcement NA 3.73%
2025-04-03 2025-04-03 Extraordinary General Meeting NA 0.15%
2025-02-18 2025-02-18 Change Of Name NA 0.00%
2025-01-23 2025-01-23 Quarterly Result Announcement NA -0.08%
2024-10-22 2024-10-22 Quarterly Result Announcement NA -4.95%
2024-09-28 2024-09-28 Annual General Meeting NA 0.00%
2024-01-20 2024-01-20 Extraordinary General Meeting NA 10.00%

Gujarat Inject Competitors Screener - Peer Stocks Comparison

Screen GUJINJEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 424,634 39.93 54,729 9.71% 10,980 49.55
Divis Laboratories 172,860 69.20 9,712 18.67% 2,191 56.33
Torrent Pharmaceuticals 129,151 60.10 11,539 6.99% 1,911 61.47
Cipla 122,205 22.55 28,410 7.12% 5,291 49.47
Dr Reddys Laboratories 107,114 18.60 33,741 16.73% 5,725 60.05
Lupin 97,120 22.34 22,910 13.74% 3,306 65.28
Zydus Life Science 92,392 18.40 23,511 18.55% 4,615 40.07
Mankind Pharma 90,241 50.59 12,744 20.90% 2,007 45.53
Aurobindo Pharma 71,119 20.79 32,346 9.43% 3,484 59.88
Alkem Laboratories 67,243 27.59 13,458 3.70% 2,216 49.80

Gujarat Inject Company Announcements - News & Reports Screener

Screen GUJINJEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 26, 2026.

The next most recent announcements are dated December 9, 2025 and November 13, 2025.

Date Update Actions
2026-09-26 Announcement under Regulation 30 (LODR)-Resignation of Director -
2025-12-09 Announcement under Regulation 30 (LODR)-Resignation of Director -
2025-11-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025 -
2025-11-13 UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025. -
2025-11-10 Board Meeting Intimation for Un-Audited Financial Results (Standalone) Of The Company For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report Of The Statutory Auditors Thereon; -
2025-10-30 Board Meeting Outcome for Outcome Of Board Meeting Dated Thursday 30Th October 2025 -
2025-10-03 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-10-01 Closure of Trading Window -
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-10 Reg. 34 (1) Annual Report. -
2025-09-10 Notice Of 34Th Annual General Meeting Along With Annual Report Of The Company For F.Y. 2024-25. -
2025-09-08 Board Meeting Outcome for Change Of Object Of The Company. -
2025-08-14 Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 14Th August 2025 -
2025-08-14 FINANCIAL RESULTS 30.06.2025 -
2025-08-11 Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June 2025 -
2025-07-25 Revised Outcome Of The Board Meeting Held On 07Th July 2025 -
2025-07-15 Announcement under Regulation 30 (LODR)-Cessation -
2025-07-07 Announcement under Regulation 30 (LODR)-Change in Directorate -
2025-07-07 Board Meeting Outcome for Outcome Of Board Meeting Dated 07Th July 2025 -
2025-07-01 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹9.09, within a 52-week range of ₹9.08 to ₹130.90. The P/E ratio is 15.00 and the P/B ratio is 4.75, with earnings per unit of ₹0.70. Market capitalisation stands at ₹48.99 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.